Kevin Brady
Impact in
-
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Glycosylation and Glycoproteins Research 4
- Protein purification and stability 4
- Chemical Synthesis and Analysis 3
-
- Monoclonal and Polyclonal Antibodies Research 11
- Co-authors
- Paul N. Moynagh (4 shared papers)Jens Niewoehner (2 shared papers)Per‐Ola Freskgård (2 shared papers)Bryan D. Griffin (1 shared paper)Daniel O’Toole (1 shared paper)Ralf J. Hosse (1 shared paper)Sarah Howlett (1 shared paper)Pablo Umaña (1 shared paper)
- Journals
- ChemBioChem (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Xenobiotica (2 papers)Biochemical Journal (2 papers)mAbs (2 papers)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Kevin Brady
28 papers receiving 606 citations
Peers
Comparison fields: 5 of 75
- Immunology 154
- Radiology, Nuclear Medicine and Imaging 110
- Neurology 40
- Pharmacology 77
- Biological Psychiatry 10
Countries citing papers authored by Kevin Brady
This map shows the geographic impact of Kevin Brady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Brady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Brady more than expected).
Fields of papers citing papers by Kevin Brady
This network shows the impact of papers produced by Kevin Brady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Brady. The network helps show where Kevin Brady may publish in the future.
Co-authors
The 25 scholars most cited alongside Kevin Brady, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 107 | |
| 2 | 2023 | 82 | |
| 3 | 2018 | 70 | |
| 4 | 2005 | 56 | |
| 5 | 1993 | 52 | |
| 6 | 2011 | 42 | |
| 7 | 2022 | 30 | |
| 8 | 2011 | 30 | |
| 9 | 1999 | 21 | |
| 10 | 1999 | 19 | |
| 11 | 2023 | 15 | |
| 12 | 2001 | 15 | |
| 13 | 2001 | 12 | |
| 14 | 1992 | 11 | |
| 15 | 2011 | 10 | |
| 16 | 2000 | 10 | |
| 17 | 2022 | 7 | |
| 18 | 2003 | 6 | |
| 19 | 2012 | 6 | |
| 20 | 2012 | 5 |
About Kevin Brady
Kevin Brady is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Immunology, Oncology and Physiology, having authored 29 papers that have together received 626 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (11 papers), Glycosylation and Glycoproteins Research (4 papers), Immune Cell Function and Interaction (4 papers), Protein purification and stability (4 papers), Chemical Synthesis and Analysis (3 papers), Peptidase Inhibition and Analysis (3 papers), Galectins and Cancer Biology (2 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Immunology (154 citations), Radiology, Nuclear Medicine and Imaging (110 citations), Neurology (40 citations), Pharmacology (77 citations) and Biological Psychiatry (10 citations). Kevin Brady has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Paul N. Moynagh, Jens Niewoehner, Per‐Ola Freskgård, Bryan D. Griffin, Daniel O’Toole, Ralf J. Hosse, Sarah Howlett, Pablo Umaña, Oliver Ast and John A. Todd. Their work appears in journals such as ChemBioChem, Antimicrobial Agents and Chemotherapy, Xenobiotica, Biochemical Journal and mAbs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.